In the news
30
Oct

2025

Anti-CEA affibody for improved cancer detection and imaging

team of scientists from KTH Royal Institute of Technology and Karolinska Institutet has reported the development and characterization of a new class of small non-immunoglobulin affibody proteins that bind to the highly glycosylated human carcinoembryonic antigen-related adhesion molecule 5 (CEACAM5, CEA) with high affinity.

Please click here to subscribe and read the full story


Locations
Sweden
United Kingdom
Switzerland
Denmark
France